Drugs / Liver NK cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01147380 | Jun 2010 → Dec 2014 | cirrhosis of liver, hepatocellular carcinoma | Seigo Nishida | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liver NK cells | “Liver NK cells were extracted from donor liver graft perfusate and were stimulated in vitro with IL-2.” PMID 34282496 ↗ Jul 2021 |
| Modality | Cell therapy | “adoptive transfer of deceased donor liver-derived natural killer (NK) cells” PMID 34282496 ↗ Jul 2021 |
| Route | Intravenous | “The patient received an intravenous infusion of NK cells 3-5 days after LT.” PMID 34282496 ↗ Jul 2021 |